Celularity Says It Regained Compliance With Nasdaq Minimum Bid Price And Market Value Of Listed Securities Rules; Delinquent Periodic Filing Deficiency Remains Outstanding

Benzinga Newsdesk www.benzinga.com Neutral 93.4%

Neg 0% Neu 93.4% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001752828/000149315226042495/form8-k.htm

Comments

No comments yet. Be the first!